Half-Year Trading Update Group revenues up 12% to €7.2m

Paris, France and Camberley, UK – 30 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an unaudited half year revenue update for the six months ended 30 June 2019. http://novacyt.com/wp-content/uploads/2019/07/Half-year-Trading-Update-FINAL.pdf

Visit Page

Cession du laboratoire clinique

Novacyt poursuit son objectif de création de valeur à partir de ses activités cœur de métier Paris, France et Camberley, UK – 18 Juillet 2019 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce avoir finalisé la cession de son laboratoire clinique (le « Clinical Lab ») à Cambridge Pathology BV (l’« acheteur ») pour un

Visit Page

Sale of Clinical Lab

Novacyt continues to focus on driving value from its core businesses Paris, France and Camberley, UK – 18 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces it has completed the sale of its clinical laboratory business (the “Clinical Lab”) to Cambridge Pathology BV (the “Buyer”) for a

Visit Page